AdaptHealth Corp.
AHCO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.13 | 0.00 | -0.69 | -0.15 |
| FCF Yield | 18.52% | 14.64% | -0.68% | 2.22% |
| EV / EBITDA | 4.91 | -18.68 | 7.71 | 10.06 |
| Quality | ||||
| ROIC | 4.62% | -13.73% | 2.94% | 3.88% |
| Gross Margin | 20.89% | 21.30% | 14.05% | 18.15% |
| Cash Conversion Ratio | 5.72 | -0.71 | 5.11 | 1.74 |
| Growth | ||||
| Revenue 3-Year CAGR | 3.16% | 9.25% | 41.15% | 66.72% |
| Free Cash Flow Growth | 64.65% | 915.69% | -124.26% | -53.57% |
| Safety | ||||
| Net Debt / EBITDA | 3.01 | -12.96 | 3.62 | 4.08 |
| Interest Coverage | 2.08 | -4.59 | 1.74 | 2.37 |
| Efficiency | ||||
| Inventory Turnover | 18.45 | 22.16 | 19.99 | 16.32 |
| Cash Conversion Cycle | 25.19 | 30.17 | 30.58 | 30.82 |